Here is a pattern that repeats in group chats, forums and waiting rooms, week after week.
Someone starts a GLP-1. The first shot does very little. The second does a little more. Then somewhere around the fourth or fifth week, with nothing changed, the whole experience shifts. Appetite goes quiet in a way it had not before, or nausea turns up after two weeks of barely noticing it, or both at once. Same dose. Same pen. Same day of the week. Different week.
Two explanations get reached for, and both are wrong. The first is that the medication suddenly started working. The second, when the shift runs the other way, is that it suddenly stopped. The real answer is duller and far more useful, and it has a name.
What steady state actually is
Every dose you take adds medication. Every hour between doses, your body clears some of it. Steady state is the point where those two quantities match: the amount arriving with each dose equals the amount clearing between doses.
Before that point, arrivals outweigh departures and the total level climbs, week over week, on an unchanging dose. After it, the level stops climbing and starts holding. It still lifts a little on shot day and eases between shots, but it does so around a stable average instead of a rising one.
Nothing about the dose changes when this happens, because the dose was never the thing that was changing. What changes is the total amount in your system, and the total is what your body is actually responding to.
Why it takes about a month
The rule of thumb pharmacologists use is that a medication reaches steady state after roughly four to five half-lives. (If the term itself needs unpacking, our guide to semaglutide half-life and medication levels starts there.)
For the weekly GLP-1 medications the arithmetic is short. Semaglutide's half-life is about one week, so four to five half-lives is four to five weeks. Tirzepatide's is about five days and dulaglutide's about five days, which lands a little under a month. Different molecules, similar answer: the first month is the climb, and roughly the fifth week is where the climb flattens out.
If you want that arithmetic drawn out dose by dose, we have done it twice already, once for semaglutide's one-week half-life and once for tirzepatide's five-day half-life. Neither article is required reading for this one. This one is about what the climb feels like from the inside.
It is worth noting that the month-long climb is a weekly-medication phenomenon. Liraglutide, the daily injection in Saxenda and Victoza, has a half-life of about 13 hours, so the same four to five half-lives are done inside a few days. The daily medications get to their plateau almost immediately and then spend their titration climbing dose steps instead. Why the schedules differ at all is its own subject, covered in why some GLP-1s are weekly and others daily.
Why week five feels different
Start from the fact and the experience falls out of it. If the level in week five is meaningfully higher than the level in week one, and the effects of the medication scale with the level, then week five should feel different. It would be strange if it did not.
Several familiar early experiences are that one fact wearing different clothes.
- The first dose is not a preview of the dose. It is the smallest amount of medication you will ever have on board, and it is also, by design, a starting step chosen for tolerability rather than effect. Judging a medication by week one is judging a climb by its first stair.
- Appetite change often arrives late and then compounds. People frequently describe the shift as gradual and then suddenly obvious, which is what a rising level plus a personal threshold produces.
- Side effects can turn up after the quiet start. Mild in week one, more noticeable as the level builds, then often settling as the body adapts. A rough week three does not mean something went wrong in week three.
- And the plateau itself feels like something. When the level stops climbing, the week-to-week change stops too, which some people read as the medication losing its grip. It has not lost anything. It has arrived.
This is why the two common explanations mislead. Both of them treat the medication as a switch that is either on or off. It is not a switch. It is a level, and for the first month that level is still in motion.
Which gives you a better question to carry through the early weeks. Not is it working yet, which cannot be answered honestly while everything is still moving, but has it leveled off yet. That single reframe is the most useful thing to understand in the first two months, because it tells you when your own experience has become informative.
GLP 1 Tracker AppFree on the App Store. Log each shot and see the first-month climb, and every plateau after it, in your own history.
Get the app
The complication: titration keeps restarting the climb
There is a wrinkle, and almost everyone starting a GLP-1 runs into it, because almost nobody spends the first months at a single dose.
Titration overlaps steady state. Dose steps on these medications are typically held for around four weeks before the next increase, which is roughly the same length as the climb itself. So the moment your level finishes settling, the dose goes up, and the climb starts again toward a new and higher plateau.
Two consequences follow, and both explain things people find confusing.
The first is that during titration you are usually somewhere in the middle of a climb rather than sitting on a plateau. A true, long, uneventful steady state mostly belongs to the period after your dose stops moving, which is one reason maintenance often feels calmer than the ramp did.
The second is the return of side effects after each step. The first month is not a one-time initiation you graduate from; it is a shape that repeats in miniature every time the dose increases, which is why nausea commonly comes back for a stretch after an increase and then eases again, per the pattern described across this medication class. Our guide to GLP-1 titration schedules covers the ladders themselves and why they climb so deliberately.
What to actually track through it
If the level is moving for a month at a time, then any single day is a poor witness. The thing worth recording is the trend, and the thing worth ignoring is most of the day-to-day noise.
In practice that means a few small habits.
- Timestamp every dose. Without real dates, none of the timing above is anchored to anything, and week four becomes an impression rather than a fact.
- Note appetite and fullness rather than delivering verdicts. A short line about how a meal went is more useful three weeks later than a daily judgment on whether the medication is working.
- Record side effects with severity and dates. The pattern you are looking for is clustering after dose changes, and that only becomes visible if the entries carry dates.
- Read weight as a line, not a reading. Over a month of a rising level, the shape matters and the individual mornings do not.
And one comparison to avoid. Week one on a new step is not comparable to week four on the old one; that is a climb measured against a plateau, and it will always flatter the plateau. Compare like with like, which usually means comparing the end of one step with the end of the next. Our two-minute daily logging routine covers the minimum that survives contact with real life.
GLP 1 Tracker App draws this as an educational medication level curve built from the doses you log, so the first-month climb, the plateau and the fresh climb after an increase are all visible in your own history. It is worth being blunt about what that picture is: an estimate for education, built from published half-life values, never a measurement of your blood. Absorption and clearance vary from person to person, only a laboratory test measures a real level, and the app does not advise doses.
The takeaway
Week five feels different because week five is different, in the only way that matters. There is more medication in you than there was in week one, from doses you already took, and the arithmetic that got it there was running quietly the whole time.
Nothing kicked in. Nothing wore off. A level that had been climbing since your first injection arrived where it was going. Hold onto the reframe that comes with that: in the first two months, the useful question is not whether the medication is working but whether the level has finished moving. Until it has, you are reading a system in transit. Give it the month, keep the record, and judge the plateau rather than the climb.
Watch your first month take shapeDose ladders, an educational level curve and a side effect diary. No account, nothing leaves your phone.
Download
Frequently asked questions
Why does a GLP-1 feel different in week five than in week one?
Because there is more medication in you, from doses you already took. These medications clear slowly, so each dose lands on top of what is left from earlier ones and the total level climbs for the first few weeks before it settles. The injection is identical and the dose is identical; the amount your body is responding to is not. That climb is what pharmacology calls the approach to steady state.
What does steady state mean in plain English?
It is the point where the amount of medication arriving with each dose equals the amount clearing between doses. Before it, arrivals outweigh departures and the level rises. After it, the level stops climbing and starts holding, lifting a little on shot day and easing between shots around a stable average. Steady state is a plateau, not a threshold that switches anything on.
Does reaching steady state mean the medication has stopped building up?
Yes, at that dose. The level keeps rising and falling within each dosing cycle, but it is no longer trending upward week over week, because clearance has caught up with intake. Getting there takes four to five half-lives, which for the weekly medications is roughly a month of accumulation. Raising the dose starts a new climb.
Does a dose increase restart the climb to steady state?
Yes. A higher dose means more medication arriving each week, so the level climbs again toward a new and higher plateau, taking roughly the same amount of time to settle as the first one did. That is one reason side effects commonly return for a while after each titration step and then ease, per the pattern described across the prescribing information for this class. Your prescriber sets the ladder and the timing.
Does one missed dose reset steady state?
No. With medications that clear this slowly, a single late or skipped dose leaves a dip in the level rather than a reset to zero, and the level recovers over the following weeks once regular dosing resumes. What to do about the missed dose itself comes from your product label and your prescriber, and the windows differ by medication. Never take a double dose to catch up.